Lasio virus
Practice this intermediate market entry case interview question from McKinsey in the Healthcare sector. Includes detailed problem prompt, clarifying questions, structured framework, and expert recommendation. Part of ProHub's 835+ consulting case library.
ProHub Comment
This is a structured brainstorming and quantitative case combining creative problem-solving (Q3) with mathematical analysis (Q4). The case teaches candidates to develop multi-dimensional solutions addressing awareness, access, experience, and incentives while also stress-testing assumptions through calculation and contextualization.
Estimated Time
27 minutes
Difficulty
Medium
Source
PeterK
40
/ 100
Not explicitly labeled in provided pages - Case concerns increasing Lasio virus vaccination rates in a country, with two main questions: Q3 asks for suggestions to increase vaccinated children numbers (assuming reliable vaccine supply and no patient costs), and Q4 is a math exercise asking for minimum vaccines needed to achieve 90% vaccination rate.
Clarifying Information
Q3 Clarifying Information (if asked):
- A lack of trust in the safety of vaccines and a belief that Lasio threat is exaggerated might contribute to the vaccine hesitancy
- Potentially low urbanization rate might suggest low population density and thus lead to accessibility issues
- Great patient experience might drive word of mouth
- Although not game-changing, some additional benefits might increase attractiveness of vaccination to low-income families
Q4 Clarifying Information (provided):
- Current vaccination results: 50% of children are fully vaccinated (received 2 doses), 20% of children received 1 dose, 30% of children didn’t receive any doses
- Children of all age groups are subject to vaccination
- Due to poor storage conditions and inadequate vaccine demand forecasting, 25% of vaccines go to waste
- The children population is 5M in this country
- The children population growth rate can be neglected [for the purposes of this calculation]